The influence of multimodal behavioral treatment on the consumption of acute migraine drugs: A randomized, controlled study

Cephalalgia

Volumn 32, Issue 4, 2012, Pages 297-307

  Hedborg, Kerstin ^a,b   Muhr, Carin ^b  

^a UNIVERSITY OF GÄVLE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

drug efficacy; drug use; gender; medication; Migraine; multimodal behavioral treatment

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; CHLORCYCLIZINE; CHLORZOXAZONE; CODEINE; DEXTROPROPOXYPHENE; DIAZEPAM; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZEPAM; PARACETAMOL;

ADULT; AGED; ARTICLE; BEHAVIOR THEORY; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MALE; MENTAL STRESS; MIGRAINE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANALGESICS; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; TRYPTAMINES; YOUNG ADULT;

EID: 84858415857     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412437386     Document Type: Article

References (32)

1. Nash JM, Thebarge RW. Understanding psychological stress, its biological processes, and impact on primary headache. Headache. 2006 ; 46: 1377-1386 (Pubitemid 44556428)
2. Hedborg K, Anderberg UM, Muhr C. Stress in migraine: personality- dependent vulnerability, life events, and gender are of significance. Ups J Med Sci. 2011 ; 116: 187-199
3. Sauro KM, Becker WJ. The stress and migraine interaction. Headache. 2009 ; 49: 1378-1386
4. Wacogne C, Lacoste JP, Guillibert E, et al. Stress, anxiety, depression and migraine. Cephalalgia. 2003 ; 23: 451-455 (Pubitemid 36776061)
5. Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci. 2007 ; 28 (Suppl 2). S70 - S77 (Pubitemid 46813630)
6. Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009 ; 27: 445-465
7. Hedborg K, Muhr C. Multimodal behavioral treatment of migraine: an Internet-administered, randomized, controlled trial. Ups J Med Sci. 2011 ; 116: 169-186
8. Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006 ; 26: 199-207
9. Holroyd KA, France JL, Cordingley GE, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol. 1995 ; 63: 327-330
10. Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 2002 ; 42: 845-854 (Pubitemid 35285373)
11. Rains JC, Penzien DB, McCrory DC, et al. Behavioral headache treatment: history, review of the empirical literature, and methodological critique. Headache. 2005 ; 45 (Suppl 2). S92 - S109 (Pubitemid 40846456)
12. Bigal ME, Lipton RB, Krymchantowski AV. The medical management of migraine. Am J Ther. 2004 ; 11: 130-140
13. Sheftell FD, Bigal ME, Tepper SJ, et al. Sumatriptan: a decade of use and experience in the treatment of migraine. Expert Rev Neurother. 2004 ; 4: 199-209 (Pubitemid 38315940)
14. Cevoli S, D'Amico D, Martelletti P, et al. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009 ; 29: 1285-1293
15. Lipton RB, Scher AI, Steiner TJ, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003 ; 60: 441-448 (Pubitemid 36188240)
16. Morillo LE, Alarcon F, Aranaga N, et al. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache. 2005 ; 45: 118-126 (Pubitemid 40315780)
17. Hedberg N and Ramsberg J. The survey of migraine drugs. The Dental and Pharmaceutical Benefits Agency, TLV (former LFN) Solna, Sweden, 2004.
18. Ramsberg J, Henriksson M. The cost-effectiveness of oral triptan therapy in Sweden. Cephalalgia. 2007 ; 27: 54-62 (Pubitemid 46020802)
19. Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002 ; 22: 633-658 (Pubitemid 36609333)
20. Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001 ; 358: 1668-1675 (Pubitemid 33124324)
21. Gawel MJ, Worthington I, Maggisano A. A systematic review of the use of triptans in acute migraine. Can J Neurol Sci. 2001 ; 28: 30-41
22. Membe S, McGahan L, Cimon K, et al. Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness. Canadian Agency for Drugs and Technologies in Heath, Technology Report No. 76, www.cadth.ca/media/ pdf/I4001-tr-Triptans-e.pdf (2007, accessed 19 January 2012).
23. Bigal M, Rapoport A, Aurora S, et al. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden. Headache. 2007 ; 47: 475-479 (Pubitemid 46625257)
24. Malik SN, Hopkins M, Young WB, et al. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache. 2006 ; 46: 773-780
25. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24(Suppl 1): 9-160.
26. Tfelt-Hansen P, Block G, Dahlöf C, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000 ; 20: 765-786 (Pubitemid 32154559)
27. Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication-a review. Cephalalgia. 2004 ; 24: 321-332 (Pubitemid 38621810)
28. Diener HC, Bussone G, de Liano H, et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia. 2004 ; 24: 947-954 (Pubitemid 39471921)
29. Eggen AE. Pattern of drug use in a general population-prevalence and predicting factors: the Tromsø study. Int J Epidemiol. 1994 ; 23: 1262-1272
30. Verbrugge LM. Gender and health: an update on hypotheses and evidence. J Health Soc Behav. 1985 ; 26: 156-182
31. Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002 ; 27: 163-181 (Pubitemid 34848001)
32. Dahlöf C, Linde M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia. 2001 ; 21: 664-671 (Pubitemid 32762789)